Eduard Ródenas Alesina
Médico Adjunto- Cardiología
- Hospital Universitari Sagrat Cor
- Adjunto del servicio de Cardiología del Hospital Universitario Vall d’Hebron (2022)
- Cardiólogo en Hospital Universitari Sagrat Cor (2022).
- Residencia de Cardiología en el Hospital Universitario Vall d’Hebron (2016 – 2021)
- Fellowship en Insuficiencia Cardíaca y Trasplante en Toronto General Hospital (2021 – 2022)
- Graduado en Medicina (2015)
- Especialista en Cardiología (2021)
- Fellowship en Insuficiencia Cardíaca y Trasplante (2022)
- Máster en Metodología de la Investigación (2022)
- Posgrado en Cardiopatías Familiares (2021)
- Máster en Arritmología Clínica (2021)
- Máster en Cuidados Agudos y Críticos Cardiológicos (2021)
- Ecocardiograma transtorácico, Holter ECG, Holter de presión arterial (MAPA)
Investigación:
- Líneas de investigación en curso sobre insuficiencia cardíaca avanzada y trasplante cardíaco, así como sobre técnicas de análisis de deformación miocárdica.
Docencia:
- Profesor de la academia CTO (2016 – 2021)
Alrededor de 15 publicaciones en revistas de Cardiología nacionales e internacionales:
1) Ródenas E, Escalona R, Pariggiano I, Oristrell G, Miranda B, Belahnech Y, et al. Individual trends in LDL-C control in patients with previous myocardial infarction. REC: CardioClinics (2020) 55(1) 23-29.
2) Francisco-Pascual J, Ródenas E, Belahnech Y, Pérez-Rodon J, Santos-Ortega S, Benito B, et al. Syncope in patients with severe aortic stenosis: more than only an obstructive issue. Can J Cardiol. 2020;S0828-282X(20)30467-0. doi:10.1016/j.cjca.2020.04.047
3) Faroux L, Campelo-Parada F, Muñoz-García E, Nombela-Franco L, Fischer Q, Donaint P et al. Procedural Characteristics and Late Outcomes of Percutaneous Coronary Intervention in the Workup Pre-TAVR: Late outcomes of pre-TAVR PCI. JACC: Cardiovasc Interv. 2020 Nov 23;13(22):2601-2613.
4) Francisco-Pascual J, Rodenas-Alesina E, Rivas-Gandara N, Belahnech Y, Olivella San Emeterio A, Perez-Rodon et al. Etiology and prognosis of patients with unexplained syncope and mid-range left ventricular dysfunction. Heart Rhythm. 2021 Apr;18(4):597-604.
5) Ribera A, Gimenez E, Oristrell G, Osorio D, Marsal JR, Garcia-Perez et al. Cost-effectiveness of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. Rev Esp Cardiol (Engl Ed). 2021 Jun 4; S1885-5857(21)00157-2.
6) Rodenas-Alesina E, Jordan P, Herrador L, Espinet-Coll C, Pizzi MN, Romero-Farina G. Q waves in ischemic cardiomyopathy. Int J Cardiovasc Imaging. 2021 Jun;37(6):2085-2092.
7) Rodenas-Alesina E, Billia F, Rao V, Ross HJ, Aleksova N. Do elderly patients with advanced heart failure have better outcomes after LVAD? JACC. 2021 Dec 21;78(25):e321.
8) Rodenas-Alesina E, Cabeza-Martinez P, Zamora-Putin V, Pariggiano I, Escalona R, Belahnech Y et al. Long-term variation in kidney function and its impact after an acute myocardial infarction. Am J Cardiol. 2022 Jan 15;163:20-24.
9) Bañeras J, Martin-Cabeza MM, Barrionuevo-Sanchez MI, Lukic Otanovic A, Rodenas-Alesina E, Jorge-Perez P. Training in cardiopulmonary resuscitation in Spanish schools: time to react. Rev Esp Cardiol. 2021 Dec 17 S1885-5857(21)00354-6. Online ahead of print.
10) Alperi A, Mohammadi S, Campelo-Parada F, Muñoz-Garcia E, Nombela-Franco L, Faroux L et al. Transcatheter versus surgical aortic valve replacement in patients with complex coronary artery disease. J Am Coll Cardiol Intv. 2021 Nov, 14 (22) 1490-2499.
11) González-del-Hoyo M, Servato L, Rodenas-Alesina E, Bañeras J, Ferreira-González I, Rodríguez-Palomares JF. Clinical impacto n treatment and prognosis of advanced cardiac imaging with echocardiography in the acute setting of a COVID19 infection. REC. Accepted. Not yet published.
12) Romero-Farina G, Aguadé-Bruix S, Ródenas-Alesina E, Herrador L, Jordán P, Ferreira-González I. Usefulness of the Vall d'Hebron Risk Score to stratify the risk of patients with ischemic cardiomyopathy. J Nucl Cardiol. 2022 Aug 8. doi: 10.1007/s12350-022-03074-6. Epub ahead of print. PMID: 35941322.
13) Ródenas-Alesina E, Romero-Farina G, Jordán P, Herrador L, Espinet-Coll C, Pizzi MN, Ribera A, Barrabés JA, Aguadé-Bruix S, Ferreira-González I. Impact of revascularization guided by functional testing in ischaemic cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2022 Jul 4:jeac125. doi: 10.1093/ehjci/jeac125. Epub ahead of print. PMID: 35781510.
14) Ródenas-Alesina E, Rodríguez-Palomares J, Bach-Oller M, Jordán P, Badia C, Herrador L, García-de-Acilu M, Clau-Terré F, González-Del-Hoyo M, Fernández-Galera R, Servato L, Casas G, Bañeras J, Ferreira-González I. Echocardiographic assessment of COVID19 sequelae in survivors with elevated cardiac biomarkers. Int J Cardiol. 2022 Aug 1;360:104-110. doi: 10.1016/j.ijcard.2022.04.070. Epub 2022 Apr 29. PMID: 35490788; PMCID: PMC9050195.
15) Bañeras J, Pariggiano I, Ródenas-Alesina E, Oristrell G, Escalona R, Miranda B, Rello P, Soriano T, Gordon B, Belahnech Y, Calabrò P, García-Dorado D, Ferreira-González I, Radua J. Optimal opportunistic screening of atrial fibrillation using pulse palpation in cardiology outpatient clinics: Who and how. PLoS One. 2022 Apr 21;17(4):e0266955. doi: 10.1371/journal.pone.0266955. PMID: 35446875; PMCID: PMC9022883.
16) Rodenas-Alesina E, Wang VN, Brahmbhatt DH, Scolari FL, Mihajlovic V, Fung NL, Otsuki M, Billia F, Overgaard CB, Luk A. CALL-K score: predicting the need for renal replacement therapy in cardiogenic shock. Eur Heart J Acute Cardiovasc Care. 2022 Jun 14;11(5):377-385. doi: 10.1093/ehjacc/zuac024. PMID: 35303055.
17) Amadio JM, Rodenas-Alesina E, Superina S, Kozuszko S, Tsang K, Simard A, Aleksova N, Kobulnik J, Fan CS, Wijeysundera HC, Ross HJ, McDonald MA, Duero Posada JG, Moayedi Y. Sparing the Prod: Providing an Alternative to Endomyocardial Biopsies With Noninvasive Surveillance After Heart Transplantation During COVID-19. CJC Open. 2022 May;4(5):479-487. doi: 10.1016/j.cjco.2022.02.002. Epub 2022 Feb 13. PMID: 35187463; PMCID: PMC8842090.
Más de 30 presentaciones en congresos de Cardiología nacionales e internacionales:
1) Clinical and electrocardiographical predictors for syncope in patients with severe aortic stenosis.
2018 Spanish Society of Cardiology Congress (first author).
2018 European Society of Cardiology Congress.
2) Etiology of the syncope in patients with severe aortic stenosis.
2018 Catalan Society of Cardiology Congress (first author)
2018 European Society of Cardiology Congress.
3) Associated factors contributing to syncope in patients with severe aortic stenosis.
2018 Catalan Society of Cardiology Congress (first author).
4) Opportunistic screening in primary care by radial artery palpation can optimally detect atrial fibrillation.
2018 American Heart Association Congress.
5) Prognostic impact of reaching an etiological diagnosis for syncope in patients with severe aortic stenosis.
2019 Catalan Society of Cardiology Congress (first author).
6) Palpitations in the emergency room.
2019, I Atrial Fibrillation Congress in Barcelona (first author).
7) ¿A simple pericarditis?
2019, XXII Cardioforo Congress in Toledo (first author).
8) Attainment of LDL cholesterol levels in an ambulatory high-risk population: tendencies through 2013-2018 and clinical predictors.
2019 Catalan Society of Cardiology Congress (first author).
2019 Spanish Society of Cardiology Congress (first author).
2019 Europrevent Congress (first author).
9) New HD-Wave algorithm vs conventional bipolar map using a new HD-Grid catheter for the scar and arrhythmogenic isthmus identification in patients with repaired great vessels transposition.
2020 Spanish Hearth Rhythm Association Congress (first author).
2020 Spanish Society of Cardiology Congress (first author).
10) Prognostic impact of revascularization considering the presence and extent of ischemia as measured by SPECT in patients with dilated ischemic cardiomyopathy
2020 Spanish Society of Cardiology Congress (first author).
11) Revascularization benefit in non-viable myocardium accounting for residual ischemic myocardium.
2020 Spanish Society of Cardiology Congress.
12) Relationship between Q waves with myocardial viability and necrosis extent in patients with dilated ischemic cardiomyopathy.
2020 Spanish Society of Cardiology Congress.
2020 EACVI Congress (first author)
13) Prognostic benefit of non-urgent revascularization according to the symptoms in patients with dilated ischemic cardiomyopathy.
2020 Spanish Society of Cardiology Congress.
2020 EACVI Congress
14) Albuminuria and glomerular filtration rate decline as a predictor of cardiovascular events.
2021 Spanish Society of Cardiology Congress
2021 Catalan Society of Cardiology Congress
15) Routine advanced echocardiography in the evaluation of cardiovascular sequelae of COVID19 survivors with elevated cardiovascular biomarkers.
2021 ESCIM Lives Congress
2021 ESC Congress (first author).
2021 Spanish Society of Cardiology Congress
16) Creation of a risk score in patients with ischemic cardiomyopathy.
2021 Spanish Society of Cardiology Congress
17) Interaction between ischemia and revascularization in ischemic cardiomyopathy.
2021 Spanish Society of Cardiology Congress
18) Impact of atrial fibrillation in myocardial deformation in patients with non-ischemic cardiomyopathy.
2021 Spanish Society of Cardiology Congress
19) Echocardiographic determinants of right ventricular function in patients with non-ischemic cardiomyopathy.
2021 Spanish Society of Cardiology Congress
2021 European HF Congress
20) Impact on prognosis of successful percutaneous closure of paravalvular mitral leaks.
2021 Spanish Society of Cardiology Congress
21) Cardiopulmonary resuscitation training in Spanish schools: when first link is not well recognized.
2021 Acute cardiovascular (ACVC) care congress
2021 Spanish Society of Cardiology Congress
22) Knowledge of the chain of survival in Spanish schoolchildren
2021 Spanish Society of Cardiology Congress
23) Prognostic role of myocardial work in left ventricular non-compactation.
2021 Spanish Society of Cardiology Congress
24) Impact of advanced cardiac imaging in management and prognosis during the acute phase of COVID19 patients
2021 Spanish Society of Cardiology Congress
25) Predictors of heart failure hospitalization and cardiovascular mortality in patients with right chronic ventricular pacing.
2021 ESC Congress
26) Poke not Prod: First Canadian experience using donor-derived cell-free DNA to replace endomyocardial biopsies during COVID-19
2022 ISHLT Congress (first author)
- Beca Magda Heras de la Sociedad Española de Cardiología
HOSPITAL UNIVERSITARI SAGRAT COR
C/ Viladomat, 288
08029 Barcelona
© 2024 Quirónsalud - Todos los derechos reservados